Literature DB >> 18487951

DNA hypomethylation caused by Lsh deletion promotes erythroleukemia development.

Tao Fan1, Anja Schmidtmann, Sichuan Xi, Victorino Briones, Heming Zhu, Hyung Chan Suh, John Gooya, Jonathan R Keller, Hong Xu, Jean Roayaei, Miriam Anver, Sandra Ruscetti, Kathrin Muegge.   

Abstract

Hematopoietic malignancies are frequently associated with DNA hypomethylation but the molecular mechanisms involved in tumor formation remain poorly understood. Here we report that mice lacking Lsh develop leukemia associated with DNA hypomethylation and oncogene activation. Lsh is a member of the SNF2 chromatin remodeling family and is required for de novo methylation of genomic DNA. Mice that received Lsh deficient hematopoietic progenitors showed severe impairment of hematopoiesis, suggesting that Lsh is necessary for normal hematopoiesis. A subset of mice developed erythroleukemia, a tumor that does not spontaneously occur in mice. Tumor tissues were CpG hypomethylated and showed a modest elevation of the transcription factor PU.1, an oncogene that is crucial for Friend virus induced erythroleukemia. Analysis of Lsh(-/-) hematopoietic progenitors revealed widespread DNA hypomethylation at repetitive sequences and hypomethylation at specific retroviral elements within the PU.1 gene. Wild type cells showed Lsh and Dnmt3b binding at the retroviral elements located within the PU.1 gene. On the other hand, Lsh deficient cells had no detectable Dnmt3b association suggesting that Lsh is necessary for recruitment of Dnmt3b to its target. Furthermore, Lsh(-/-) hematopoietic precursors showed impaired suppression of retroviral elements in the PU.1 gene, an increase of PU.1 transcripts and protein levels. Thus DNA hypomethylation caused by Lsh depletion is linked to transcriptional upregulation of retroviral elements and oncogenes such as PU.1 which in turn may promote the development of erythroleukemia in mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18487951      PMCID: PMC3113485          DOI: 10.4161/epi.3.3.6252

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  47 in total

1.  Chromosomal instability and tumors promoted by DNA hypomethylation.

Authors:  Amir Eden; François Gaudet; Alpana Waghmare; Rudolf Jaenisch
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

Review 2.  Epigenetics in carcinogenesis and cancer prevention.

Authors:  Peter A Jones
Journal:  Ann N Y Acad Sci       Date:  2003-03       Impact factor: 5.691

3.  Epigenetic regulation of an IAP retrotransposon in the aging mouse: progressive demethylation and de-silencing of the element by its repetitive induction.

Authors:  Willy Barbot; Anne Dupressoir; Vladimir Lazar; Thierry Heidmann
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

4.  Induction of tumors in mice by genomic hypomethylation.

Authors:  François Gaudet; J Graeme Hodgson; Amir Eden; Laurie Jackson-Grusby; Jessica Dausman; Joe W Gray; Heinrich Leonhardt; Rudolf Jaenisch
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

5.  DNA methyltransferase deficiency modifies cancer susceptibility in mice lacking DNA mismatch repair.

Authors:  Binh N Trinh; Tiffany I Long; Andrea E Nickel; Darryl Shibata; Peter W Laird
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

6.  Lsh, a modulator of CpG methylation, is crucial for normal histone methylation.

Authors:  Qingsheng Yan; Jiaqiang Huang; Tao Fan; Heming Zhu; Kathrin Muegge
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

Review 7.  DNA demethylating agents and chromatin-remodelling drugs: which, how and why?

Authors:  Ana Villar-Garea; Manel Esteller
Journal:  Curr Drug Metab       Date:  2003-02       Impact factor: 3.731

8.  Growth retardation and premature aging phenotypes in mice with disruption of the SNF2-like gene, PASG.

Authors:  Lin-Quan Sun; David W Lee; Quangeng Zhang; Weihong Xiao; Eric H Raabe; Alan Meeker; Dengshun Miao; David L Huso; Robert J Arceci
Journal:  Genes Dev       Date:  2004-04-22       Impact factor: 11.361

Review 9.  Altered methylation patterns in cancer cell genomes: cause or consequence?

Authors:  Stephen Baylin; Timothy H Bestor
Journal:  Cancer Cell       Date:  2002-05       Impact factor: 31.743

10.  Lsh-deficient murine embryonal fibroblasts show reduced proliferation with signs of abnormal mitosis.

Authors:  Tao Fan; Qingsheng Yan; Jiaqiang Huang; Sharon Austin; Edward Cho; Doug Ferris; Kathrin Muegge
Journal:  Cancer Res       Date:  2003-08-01       Impact factor: 12.701

View more
  22 in total

1.  Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma.

Authors:  Björn Lamprecht; Korden Walter; Stephan Kreher; Raman Kumar; Michael Hummel; Dido Lenze; Karl Köchert; Mohamed Amine Bouhlel; Julia Richter; Eric Soler; Ralph Stadhouders; Korinna Jöhrens; Kathrin D Wurster; David F Callen; Michael F Harte; Maciej Giefing; Rachael Barlow; Harald Stein; Ioannis Anagnostopoulos; Martin Janz; Peter N Cockerill; Reiner Siebert; Bernd Dörken; Constanze Bonifer; Stephan Mathas
Journal:  Nat Med       Date:  2010-05-02       Impact factor: 53.440

2.  DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis.

Authors:  Mrinal Y Shah; Aparna Vasanthakumar; Natalie Y Barnes; Maria E Figueroa; Anna Kamp; Christopher Hendrick; Kelly R Ostler; Elizabeth M Davis; Shang Lin; John Anastasi; Michelle M Le Beau; Ivan P Moskowitz; Ari Melnick; Peter Pytel; Lucy A Godley
Journal:  Cancer Res       Date:  2010-06-29       Impact factor: 12.701

Review 3.  DNA hypomethylation in the origin and pathogenesis of human diseases.

Authors:  Igor P Pogribny; Frederick A Beland
Journal:  Cell Mol Life Sci       Date:  2009-03-27       Impact factor: 9.261

4.  Roles of retrotransposons in benign and malignant hematologic disease.

Authors:  Anna M Schneider; Amy S Duffield; David E Symer; Kathleen H Burns
Journal:  Cellscience       Date:  2009-10-27

Review 5.  The ghosts in the machine: DNA methylation and the mystery of differentiation.

Authors:  Victorino Briones; Kathrin Muegge
Journal:  Biochim Biophys Acta       Date:  2012-02-22

Review 6.  Response of transposable elements to environmental stressors.

Authors:  Isabelle R Miousse; Marie-Cecile G Chalbot; Annie Lumen; Alesia Ferguson; Ilias G Kavouras; Igor Koturbash
Journal:  Mutat Res Rev Mutat Res       Date:  2015-05-30       Impact factor: 5.657

7.  Lsh mediated RNA polymerase II stalling at HoxC6 and HoxC8 involves DNA methylation.

Authors:  Yongguang Tao; Sichuan Xi; Victorino Briones; Kathrin Muegge
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

8.  Lsh participates in DNA methylation and silencing of stem cell genes.

Authors:  Sichuan Xi; Theresa M Geiman; Victorino Briones; Yong Guang Tao; Hong Xu; Kathrin Muegge
Journal:  Stem Cells       Date:  2009-11       Impact factor: 6.277

Review 9.  DNA hypomethylation in cancer cells.

Authors:  Melanie Ehrlich
Journal:  Epigenomics       Date:  2009-12       Impact factor: 4.778

Review 10.  Environmental toxicants, epigenetics, and cancer.

Authors:  Igor P Pogribny; Ivan Rusyn
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.